Clinical Trial Detail

NCT ID NCT01638676
Title A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors James Graham Brown Cancer Center
Indications

melanoma

Therapies

Metformin + Vemurafenib

Age Groups: adult

Additional content available in CKB BOOST